MUFG Americas’s Elevance Health ELV Stock Holding History

MUFG Americas’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,675	Closed	-$3.56M	–	818
2021 Q4	$3.56M	Buy	+7,675	New	+$3.23M	0.07%	201

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MUFG Americas's ELV Position: Q4 2022 in Review

MUFG Americas sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 38,085 shares — an estimated $17.3M sold.

MUFG Americas first reported a position in ELV in Q2 2013 and held it in 38 quarters. The position peaked at $18M in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

MUFG Americas reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
MUFG Americas sold 38,085 Elevance Health shares in Q4 2022, an estimated $17.3M.
MUFG Americas first reported a position in Elevance Health in Q2 2013 and held it in 38 quarters.
MUFG Americas's Elevance Health position peaked at $18M in Q1 2022.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.